Metformin, at Concentrations Corresponding to the Treatment of Diabetes, Potentiates the Cytotoxic Effects of Carboplatin in Cultures of Ovarian Cancer Cells
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metformin, at Concentrations Corresponding to the Treatment of Diabetes, Potentiates the Cytotoxic Effects of Carboplatin in Cultures of Ovarian Cancer Cells
Authors
Keywords
-
Journal
Reproductive Sciences
Volume 20, Issue 12, Pages 1433-1446
Publisher
SAGE Publications
Online
2013-05-08
DOI
10.1177/1933719113488441
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metformin Suppresses Ovarian Cancer Growth and Metastasis with Enhancement of Cisplatin Cytotoxicity In Vivo
- (2015) Ramandeep Rattan et al. NEOPLASIA
- Metformin Use Is Associated with Better Survival of Diabetic Patients with Pancreatic Cancer
- (2012) N. Sadeghi et al. CLINICAL CANCER RESEARCH
- Metformin kills and radiosensitizes cancer cells and preferentially kills cancer stem cells
- (2012) Chang W. Song et al. Scientific Reports
- Understanding the benefit of metformin use in cancer treatment
- (2011) Ryan JO Dowling et al. BMC Medicine
- Metformin, Independent of AMPK, Induces mTOR Inhibition and Cell-Cycle Arrest through REDD1
- (2011) I. Ben Sahra et al. CANCER RESEARCH
- Establishment of a Database of Metformin Plasma Concentrations and Erythrocyte Levels in Normal and Emergency Situations
- (2011) Jean-Daniel Lalau et al. CLINICAL DRUG INVESTIGATION
- Induction of apoptosis by metformin in epithelial ovarian cancer: Involvement of the Bcl-2 family proteins
- (2011) Amber Yasmeen et al. GYNECOLOGIC ONCOLOGY
- Identifying Inhibitors of Epithelial-Mesenchymal Transition by Connectivity Map–Based Systems Approach
- (2011) Ajaya Kumar Reka et al. Journal of Thoracic Oncology
- Metformin and cancer: new applications for an old drug
- (2011) Taxiarchis V. Kourelis et al. MEDICAL ONCOLOGY
- Relationship of Type II Diabetes and Metformin Use to Ovarian Cancer Progression, Survival, and Chemosensitivity
- (2011) Iris L. Romero et al. OBSTETRICS AND GYNECOLOGY
- Metformin as an antitumor agent in cancer prevention and treatment
- (2011) Donghui LI Journal of Diabetes
- Increased Expression of Annexin A3 Is a Mechanism of Platinum Resistance in Ovarian Cancer
- (2010) X. Yan et al. CANCER RESEARCH
- Effects of Rosiglitazone/Metformin Fixed-Dose Combination Therapy and Metformin Monotherapy on Serum Vaspin, Adiponectin and IL-6 Levels in Drug-Naïve Patients with Type 2 Diabetes
- (2010) N. P. E. Kadoglou et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- Metformin Selectively Targets Cancer Stem Cells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong Remission
- (2009) H. A. Hirsch et al. CANCER RESEARCH
- Metformin Associated With Lower Cancer Mortality in Type 2 Diabetes: ZODIAC-16
- (2009) G. W.D. Landman et al. DIABETES CARE
- Metformin attenuates ovarian cancer cell growth in an AMP-kinase dispensable manner
- (2009) R. Rattan et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Effects of Raf Kinase Inhibitor Protein Expression on Metastasis and Progression of Human Epithelial Ovarian Cancer
- (2008) H. Z. Li et al. MOLECULAR CANCER RESEARCH
- Effects of sustained and intermittent paclitaxel therapy on tumor repopulation in ovarian cancer
- (2008) V. Vassileva et al. MOLECULAR CANCER THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now